After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more

264
34
Favorite

After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more

StreetInsider2021-09-20

After-Hours Stock Movers:

Verrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.

Aprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.

SmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.

KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.

Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

264

Report

Comment（34）

FT585
·2021-09-21
Like ?
Reply
1
Report
YCGan
·2021-09-21
?
Reply
2
Report
HelloKitty55
·2021-09-21
Ok
Reply
3
Report
A68
·2021-09-21
Ok
Reply
2
Report
RIC
·2021-09-21
great news
Reply
2
Report
tan0524u
·2021-09-21
Likes for all
Reply
2
Report
Fold Replies
- EPK:
  ;-)
  2021-09-21
  Reply
  Report
Kelvinphan
·2021-09-21
Pls like
Reply
3
Report
Linnleo
·2021-09-21
Like pls
Reply
4
Report
CynthiaGho
·2021-09-21
Like pls
Reply
7
Report
Fold Replies
- hohok:
  done!
  2021-09-21
  Reply
  Report
Al3x
·2021-09-21
Like
Reply
6
Report
Fold Replies
- tan0524u:
  Done
  2021-09-21
  Reply
  Report
- CynthiaGho:
  ?
  2021-09-21
  Reply
  Report
Howhowlee
·2021-09-21
like
Reply
6
Report
Pangabui
·2021-09-21

Reply
6
Report
anniepj
·2021-09-21
It will be nice if colour code the Higher and Lower in main articles.
Reply
8
Report
Fold Replies
- AndrewL:
  ?
  2021-09-21
  Reply
  Report
FrickL
·2021-09-21
Like pls
Reply
6
Report
Elsontok
·2021-09-21
like please
Reply
5
Report
saral
·2021-09-21
Like pls thks.
Reply
4
Report
Fold Replies
- Elsontok:
  done
  2021-09-21
  Reply
  Report
孙悟空大闹天宫2
·2021-09-21
Appreciated your update! Thanks. Good job ?
Reply
2
Report
seojun
·2021-09-21
Nice sum up
Reply
3
Report
SherryVJ
·2021-09-21
Ok
Reply
3
Report
NgKenny
·2021-09-21
Nice
Reply
7
Report

7x24

All

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/2169533684?lang=en_US&edition=full_marsco","thumbnail":"","is_english":true,"pubTime":"2021-09-21 07:29","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2169533684","market":"us","top_or_hot":-1,"title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","media":"StreetInsider","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"VRCA","symbol_name":"Verrica Pharmaceuticals Inc.","start_time":0,"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","article_id":"2169533684","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","pubTimestamp":1632180546,"columns":[],"sourceInfo":{"source_id":"highlight_streetinsider","name":"StreetInsider"},"weMediaInfo":null,"summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","collect":0,"end_time":0,"defaultTopTitle":"streetinsider.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"translate_title":"下班后股票搬运工：Verrica Pharmaceutics、Aprea Therapeutics、SmileDirectClub等","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"APRE":0.9,"KAR":0.9,"LEN":0.9,"SDC":0.9,"VRCA":0.9},"content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"code":"91000000","status":"200"},"commentList":[{"id":860743456,"gmtCreate":1632219770975,"gmtModify":1676530727456,"author":{"id":"3562726241279787","authorId":"3562726241279787","name":"FT585","avatar":"https://static.tigerbbs.com/734b50619b12425294cb4715814bdedb","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3562726241279787","authorIdStr":"3562726241279787"},"htmlText":"Like ?&nbsp;","listText":"Like ?&nbsp;","text":"Like ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":1,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860743456","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860437207,"gmtCreate":1632196744309,"gmtModify":1676530723162,"author":{"id":"3577607521999934","authorId":"3577607521999934","name":"YCGan","avatar":"https://community-static.tradeup.com/news/18898f9973969d76c20791700276c04e","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3577607521999934","authorIdStr":"3577607521999934"},"htmlText":"?","listText":"?","text":"?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860437207","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860432206,"gmtCreate":1632196457605,"gmtModify":1676530723016,"author":{"id":"3587095479419511","authorId":"3587095479419511","name":"HelloKitty55","avatar":"https://static.tigerbbs.com/d60ee63e7e29d36d5bc7561ef9bc3ed6","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3587095479419511","authorIdStr":"3587095479419511"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860432206","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860430846,"gmtCreate":1632195810385,"gmtModify":1676530722866,"author":{"id":"3576813955258325","authorId":"3576813955258325","name":"A68","avatar":"https://static.tigerbbs.com/d209afa981c29a4dc34bd7c1c986fb4a","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3576813955258325","authorIdStr":"3576813955258325"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860430846","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860404455,"gmtCreate":1632194178477,"gmtModify":1676530722616,"author":{"id":"3586229488061125","authorId":"3586229488061125","name":"RIC","avatar":"https://static.tigerbbs.com/40f79c31af5e7623d32535c3123b12c2","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":2,"crmLevelSwitch":0,"idStr":"3586229488061125","authorIdStr":"3586229488061125"},"htmlText":"great news","listText":"great news","text":"great news","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860404455","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860577735,"gmtCreate":1632193074727,"gmtModify":1676530722383,"author":{"id":"3567505470517950","authorId":"3567505470517950","name":"tan0524u","avatar":"https://static.tigerbbs.com/36ccaf6467346df7588feaddbaa96926","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"3567505470517950","authorIdStr":"3567505470517950"},"htmlText":"Likes for all","listText":"Likes for all","text":"Likes for all","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860577735","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5942059,"gmtCreate":1632193937843,"gmtModify":1663234191540,"authorId":3582064943200061,"author":{"id":3582064943200061,"idStr":"3582064943200061","authorId":3582064943200061,"name":"EPK","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":7,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":860577735,"type":1,"supId":0,"prevId":0,"content":";-)","text":";-)","html":";-)"}],"langContent":"EN"},{"id":860573839,"gmtCreate":1632192331621,"gmtModify":1676530722209,"author":{"id":"3579053062900901","authorId":"3579053062900901","name":"Kelvinphan","avatar":"https://static.tigerbbs.com/dd87884547b7d5f0157a229e9ea4e890","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3579053062900901","authorIdStr":"3579053062900901"},"htmlText":"Pls like&nbsp;","listText":"Pls like&nbsp;","text":"Pls like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860573839","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860544645,"gmtCreate":1632191880587,"gmtModify":1676530722155,"author":{"id":"3584658134750205","authorId":"3584658134750205","name":"Linnleo","avatar":"https://static.tigerbbs.com/b57e83af12c17b31db1fb1b80ea44c6a","vip":1,"hat":"https://static.tigerbbs.com/4c5ceab71416b120bab4604c0754b52a","crmLevel":2,"crmLevelSwitch":0,"idStr":"3584658134750205","authorIdStr":"3584658134750205"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860544645","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860510507,"gmtCreate":1632187562209,"gmtModify":1676530720703,"author":{"id":"3585269828090771","authorId":"3585269828090771","name":"CynthiaGho","avatar":"https://static.itradeup.com/news/f4e1adb658462550fca78ca358f2bf01","vip":1,"hat":"https://static.tigerbbs.com/63f4db5a25402cce463d975948213b15","crmLevel":2,"crmLevelSwitch":0,"idStr":"3585269828090771","authorIdStr":"3585269828090771"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860510507","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5941462,"gmtCreate":1632190531488,"gmtModify":1663234187240,"authorId":3581844295426037,"author":{"id":3581844295426037,"idStr":"3581844295426037","authorId":3581844295426037,"name":"hohok","avatar":"https://static.tigerbbs.com/b9ae72338572431c58f911b40ae0f930","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":860510507,"type":1,"supId":0,"prevId":0,"content":"done!","text":"done!","html":"done!"}],"langContent":"EN"},{"id":860532091,"gmtCreate":1632187288713,"gmtModify":1676530720599,"author":{"id":"4088815138354210","authorId":"4088815138354210","name":"Al3x","avatar":"https://static.tigerbbs.com/76537eea7f5e56814a3866c383a688d2","vip":1,"crmLevel":1,"crmLevelSwitch":0,"idStr":"4088815138354210","authorIdStr":"4088815138354210"},"htmlText":"Like","listText":"Like","text":"Like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":2,"repostSize":0,"link":"https://ttm.financial/post/860532091","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5941920,"gmtCreate":1632193091331,"gmtModify":1663234192244,"authorId":3567505470517950,"author":{"id":3567505470517950,"idStr":"3567505470517950","authorId":3567505470517950,"name":"tan0524u","avatar":"https://static.tigerbbs.com/36ccaf6467346df7588feaddbaa96926","vip":1,"crmLevel":5,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":860532091,"type":1,"supId":0,"prevId":0,"content":"Done","text":"Done","html":"Done"},{"id":5940806,"gmtCreate":1632187577564,"gmtModify":1663234187234,"authorId":3585269828090771,"author":{"id":3585269828090771,"idStr":"3585269828090771","authorId":3585269828090771,"name":"CynthiaGho","avatar":"https://static.itradeup.com/news/f4e1adb658462550fca78ca358f2bf01","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":860532091,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"}],"langContent":"EN"},{"id":860538076,"gmtCreate":1632187193995,"gmtModify":1676530720559,"author":{"id":"3580900560629850","authorId":"3580900560629850","name":"Howhowlee","avatar":"https://static.tigerbbs.com/822aeb8e69b9aec5e6edcbed4485037d","vip":1,"hat":"https://static.tigerbbs.com/a3dee1aa3a3a3c1814833a4d3f8a5669","crmLevel":4,"crmLevelSwitch":1,"idStr":"3580900560629850","authorIdStr":"3580900560629850"},"htmlText":"like","listText":"like","text":"like","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860538076","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860539144,"gmtCreate":1632187021288,"gmtModify":1676530720495,"author":{"id":"3570444284639989","authorId":"3570444284639989","name":"Pangabui","avatar":"https://static.tigerbbs.com/32b4b9242d9aab94ee79aaaf573818e8","vip":1,"hat":"https://static.tigerbbs.com/f84d87792f02cf78e80ee34979fd31e5","crmLevel":2,"crmLevelSwitch":0,"idStr":"3570444284639989","authorIdStr":"3570444284639989"},"htmlText":"[微笑]&nbsp;[微笑]&nbsp;[微笑]&nbsp;","listText":"[微笑]&nbsp;[微笑]&nbsp;[微笑]&nbsp;","text":"[微笑] [微笑] [微笑]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860539144","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"CN"},{"id":860530053,"gmtCreate":1632186918772,"gmtModify":1676530720472,"author":{"id":"4090766437045130","authorId":"4090766437045130","name":"anniepj","avatar":"https://static.tigerbbs.com/04e1ab86470d448d1d57219f01a4f8fb","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"4090766437045130","authorIdStr":"4090766437045130"},"htmlText":"It will be nice if colour code the Higher and Lower in main articles.","listText":"It will be nice if colour code the Higher and Lower in main articles.","text":"It will be nice if colour code the Higher and Lower in main articles.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":8,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860530053","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5941565,"gmtCreate":1632191115532,"gmtModify":1663234192432,"authorId":3571815908504020,"author":{"id":3571815908504020,"idStr":"3571815908504020","authorId":3571815908504020,"name":"AndrewL","avatar":"https://static.tigerbbs.com/f45655eaaab14f0b61c554eea4d95ca7","vip":1,"crmLevel":2,"crmLevelSwitch":0,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":860530053,"type":1,"supId":0,"prevId":0,"content":"?","text":"?","html":"?"}],"langContent":"EN"},{"id":860596989,"gmtCreate":1632186649241,"gmtModify":1676530720347,"author":{"id":"3582151718585472","authorId":"3582151718585472","name":"FrickL","avatar":"https://community-static.tradeup.com/news/5ea265fa5b5f17bb783942b290d93a0d","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3582151718585472","authorIdStr":"3582151718585472"},"htmlText":"Like pls","listText":"Like pls","text":"Like pls","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":6,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860596989","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860500247,"gmtCreate":1632185702389,"gmtModify":1676530719983,"author":{"id":"3577246510298951","authorId":"3577246510298951","name":"Elsontok","avatar":"https://static.tigerbbs.com/5d91c4e73ceffea4b93c2c832535db3b","vip":1,"crmLevel":2,"crmLevelSwitch":1,"idStr":"3577246510298951","authorIdStr":"3577246510298951"},"htmlText":"like please","listText":"like please","text":"like please","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860500247","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860274090,"gmtCreate":1632185489410,"gmtModify":1676530719934,"author":{"id":"3568944508199908","authorId":"3568944508199908","name":"saral","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":6,"crmLevelSwitch":0,"idStr":"3568944508199908","authorIdStr":"3568944508199908"},"htmlText":"Like pls thks.","listText":"Like pls thks.","text":"Like pls thks.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/860274090","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"comments":[{"id":5940362,"gmtCreate":1632185712858,"gmtModify":1663234182445,"authorId":3577246510298951,"author":{"id":3577246510298951,"idStr":"3577246510298951","authorId":3577246510298951,"name":"Elsontok","avatar":"https://static.tigerbbs.com/5d91c4e73ceffea4b93c2c832535db3b","vip":1,"crmLevel":2,"crmLevelSwitch":1,"individualDisplayBadges":[]},"repliedAuthorId":0,"objectId":860274090,"type":1,"supId":0,"prevId":0,"content":"done","text":"done","html":"done"}],"langContent":"EN"},{"id":860276780,"gmtCreate":1632185348140,"gmtModify":1676530719873,"author":{"id":"4092785063661410","authorId":"4092785063661410","name":"孙悟空大闹天宫2","avatar":"https://static.tigerbbs.com/dee1c9fae0d12aaeaae58a13d73d3b08","vip":1,"crmLevel":9,"crmLevelSwitch":0,"idStr":"4092785063661410","authorIdStr":"4092785063661410"},"htmlText":"Appreciated your update! Thanks. Good job ?&nbsp;","listText":"Appreciated your update! Thanks. Good job ?&nbsp;","text":"Appreciated your update! Thanks. Good job ?","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860276780","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860278464,"gmtCreate":1632185247858,"gmtModify":1676530719858,"author":{"id":"4087771643270940","authorId":"4087771643270940","name":"seojun","avatar":"https://static.tigerbbs.com/3bd9ce06b0a58d0a81582641f6566970","vip":1,"crmLevel":5,"crmLevelSwitch":0,"idStr":"4087771643270940","authorIdStr":"4087771643270940"},"htmlText":"Nice sum up","listText":"Nice sum up","text":"Nice sum up","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860278464","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860257275,"gmtCreate":1632184392297,"gmtModify":1676530719493,"author":{"id":"3586426326873853","authorId":"3586426326873853","name":"SherryVJ","avatar":"https://community-static.tradeup.com/news/1881722e980e541f3c66ed217d5b91c6","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":4,"crmLevelSwitch":1,"idStr":"3586426326873853","authorIdStr":"3586426326873853"},"htmlText":"Ok","listText":"Ok","text":"Ok","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":3,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860257275","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":860256941,"gmtCreate":1632184154583,"gmtModify":1676530719390,"author":{"id":"3582778356971864","authorId":"3582778356971864","name":"NgKenny","avatar":"https://static.tigerbbs.com/4fdae3e0bdca8d3a33e7f9d619f0dc88","vip":1,"hat":"https://static.tigerbbs.com/b073a07f77dbe6b3bec6b12311fde6bd","crmLevel":1,"crmLevelSwitch":1,"idStr":"3582778356971864","authorIdStr":"3582778356971864"},"htmlText":"Nice","listText":"Nice","text":"Nice","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":7,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/860256941","repostId":2169533684,"repostType":4,"repost":{"id":"2169533684","kind":"news","pubTimestamp":1632180546,"share":"https://ttm.financial/m/news/2169533684?lang=&edition=full_marsco","pubTime":"2021-09-21 07:29","market":"us","language":"en","title":"After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more","url":"https://stock-news.laohu8.com/highlight/detail?id=2169533684","media":"StreetInsider","summary":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the ","content":"<p>After-Hours Stock Movers:</p>\n<p><a href=\"https://laohu8.com/S/VRCA\">Verrica Pharmaceuticals Inc.</a> (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for <a href=\"https://laohu8.com/S/VP..UK\">VP</a>-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.</p>\n<p><a href=\"https://laohu8.com/S/APRE\">Aprea Therapeutics, Inc.</a> (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.</p>\n<p><a href=\"https://laohu8.com/S/SDC\">SmileDirectClub, Inc.</a> (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.</p>\n<p>KAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.</p>\n<p>Lennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.</p>","source":"highlight_streetinsider","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>After-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nAfter-Hours Stock Movers: Verrica Pharmaceuticals,Aprea Therapeutics,SmileDirectClub and more\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-09-21 07:29 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.streetinsider.com/dr/news.php?id=18960708><strong>StreetInsider</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its ...</p>\n\n<a href=\"https://www.streetinsider.com/dr/news.php?id=18960708\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"VRCA":"Verrica Pharmaceuticals Inc.","APRE":"Aprea Therapeutics, Inc.","SDC":"SmileDirectClub, Inc.","LEN":"莱纳建筑公司","KAR":"OPENLANE"},"source_url":"https://www.streetinsider.com/dr/news.php?id=18960708","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2169533684","content_text":"After-Hours Stock Movers:\nVerrica Pharmaceuticals Inc. (Nasdaq: VRCA) 24% LOWER; announced that the U.S. Food and Drug Administration (FDA) has issued a Complete Response Letter (CRL) regarding its New Drug Application (NDA) for VP-102 for the treatment of molluscum contagiosum (molluscum). The Company had previously disclosed that the FDA extended the Prescription Drug User Fee Act (PDUFA) goal date for the NDA by three months to September 23, 2021 to allow the Agency additional time to review information submitted by the Company in response to comments from the Agency regarding the Companys human factors study.\nAprea Therapeutics, Inc. (Nasdaq: APRE) 15.5% HIGHER; presented data at the European Society of Medical Oncology (ESMO) Congress 2021 from its Phase I/II clinical trial in advanced solid tumors. The trial is evaluating the safety and efficacy of eprenetapopt in combination with pembrolizumab.\nSmileDirectClub, Inc. (Nasdaq: SDC) 5.6% HIGHER; announced today its plan to launch in France in the beginning of the fourth quarter of 2021. The Company will introduce its premium clear aligners, telehealth platform, and award-winning whitening system at its first France SmileShop in Paris, with additional locations to follow. This marks the Companys entry into its seventh European country as it pursues the global market opportunity for its innovative, effective, convenient, accessible and affordable oral care products. Also, downgraded to Hold at Stifel.\nKAR Auction Services (NYSE: KAR) 3% LOWER; is withdrawing its previously provided financial outlook for fiscal 2021. The company expects $95 million to $100 million of Adjusted EBITDA for the third quarter 2021 and expects approximately 2.6 million vehicles sold in 2021. Due to the market uncertainty, the company does not intend to provide fourth quarter expectations at this time.\nLennar Corp. (NYSE: LEN) 2.9% LOWER; reported Q3 EPS of $3.27, $0.01 worse than the analyst estimate of $3.28. Revenue for the quarter came in at $6.94 billion versus the consensus estimate of $6.86 billion.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":264,"commentSize":34,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}